Bentham Science Logo

Contents

Anti-Cancer Agents in Medicinal Chemistry, Volume 14 - Number 2



The Need for Improvement of the Treatment of Advanced and Metastatic Cervical Cancer, the Rationale for Combined Chemo-Immunotherapy

, 14(2): 190 - 203

Helene van Meir, Gemma G. Kenter, Jacobus Burggraaf, Judith R. Kroep, Marij J.P. Welters, Cornelis J.M. Melief, Sjoerd H. van der Burg and Mariette I.E. van Poelgeest


DOI: 10.2174/18715206113136660372



Ex Vivo-Activated MHC-Unrestricted Immune Effectors for Cancer Adoptive Immunotherapy

, 14(2): 211 - 222

Valeria Leuci, Giulia Mesiano, Loretta Gammaitoni, Maja Todorovic, Lidia Giraudo, Fabrizio Carnevale-Schianca, Massimo Aglietta and Dario Sangiolo


DOI: 10.2174/18715206113136660371


Chemical Metabolic Inhibitors for the Treatment of Blood-Borne Cancers

, 14(2): 223 - 232

Martin Villalba, Nuria Lopez-Royuela, Ewelina Krzywinska, Moeez G. Rathore, Robert A. Hipskind, Houda Haouas and Nerea Allende-Vega


DOI: 10.2174/18715206113136660374









Artesunate Enhances the Antiproliferative Effect of Temozolomide on U87MG and A172 Glioblastoma Cell Lines

, 14(2): 313 - 318

Georg Karpel-Massler, Mike-Andrew Westhoff, Richard E. Kast, Annika Dwucet, Lisa Nonnenmacher, C. Rainer Wirtz, Klaus-Michael Debatin and Marc-Eric Halatsch


DOI: 10.2174/18715206113136660340



Electrochemical Study of Ellipticine Interaction with Single and Double Stranded Oligonucleotides

, 14(2): 331 - 340

Katerina Tmejova, Ludmila Krejcova, David Hynek, Vojtech Adam, Petr Babula, Libuse Trnkova, Marie Stiborova, Tomas Eckschlager and Rene Kizek


DOI: 10.2174/18715206113139990316



Webmaster Contact: info@benthamscience.net
Copyright © 2018 Bentham Science